Webinar 2: Translating and Incorporating the New DSM-5 Diagnostic Criteria for BED into Practice

BED Webinars
1 CDR 1 AMA PRA Category 1 Credit(s)
Launch Date:
April 07, 2015
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

General Medicine and Family Physicians and Dietitians who care for patients with binge eating disorder. Other health care providers, including nurse practitioners and physician assistants, may also participate.

Relevant Terms:

Binge Eating Disorder, Eating Disorders, Obesity

Leslie Lucien Citrome, MD, MPH, DFAPA

Leslie Lucien Citrome, MD, MPH, DFAPA
Clinical Professor of Psychiatry and Behavioral Sciences
New York Medical College
Valhalla, New York

Dr. Citrome is Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College in Valhalla, New York and has a private practice in Pomona, New York. He is the Editor-in-Chief of the International Journal of Clinical Practice, published by Wiley-Blackwell.

Dr. Citrome was the founding Director of the Clinical Research and Evaluation Facility at the Nathan S. Kline Institute for Psychiatric Research in Orangeburg, New York, and after nearly two decades of government service as a researcher in the psychopharmacological treatment of severe mental disorders, Dr. Citrome is now engaged as a consultant in clinical trial design and interpretation. Dr. Citrome is a member of the Board of Directors of the American Society of Clinical Psychopharmacology.

Main areas of interest include schizophrenia, bipolar disorder and major depressive disorder. He is a frequent lecturer on the quantitative assessment of clinical trial results using the evidence-based medicine metrics of number needed to treat and number needed to harm. Dr. Citrome is the author or co-author of over 400 research reports, reviews, chapters and abstracts in the scientific literature, is on the editorial board of 9 different medical journals, reviews for over 50 other journals, and has lectured extensively throughout the USA, Canada, Europe, and Asia.

1. Assess the binge characteristics of BED in order to list how they are distinct from normal overeating and other eating disorders
2. Describe how the severity of BED is classified according to the DSM-5 diagnostic criteria
3. Evaluate how the addition of BED as a recognized disorder to the DSM-5 criteria can be used in practice to improve screening techniques and the diagnosis of BED in your at-risk patients
4. Identify misconceptions, biases, and negative attitudes commonly associated with BED in order to assess how they impact diagnosis, treatment, and communication with your at-risk patients

This educational activity is supported by an independent educational grant from Shire.

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence.
Disclosures are as follows:
Leslie Lucien Citrome, MD, MPH, DFAPA
Nature of Relationship
Commercial Entity
Consultant/Advisory Board: marketing purposes and scientific information and clinical trial design
Actavis (Forest Laboratories), Alexza, Alkermes, Bristol-Myers Squibb, Eli Lilly, Forum (Envivo), Genentech, Janssen, Jazz Pharmaceuticals, Lundbeck, Merck, Medivation, Mylan, Novartis, Noven Pharmaceuticals, Otsuka, Pfizer, Reckitt Benckiser, Reviva, Shire Pharmaceuticals, Sunovion Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceutical Industries, Ltd.
 Shareholder (small number of shares)
Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, Merck, Pfizer
Promotional Speakers’ Bureau
Actavis (Forest Laboratories), AstraZeneca, Jazz Pharmaceuticals, Lundbeck, Novartis, Otsuka, Pfizer, Shire Pharmaceuticals, Sunovion Pharmaceuticals, Takeda Pharmaceuticals, Teva Pharmaceutical Industries, Ltd.
Independent Clinical Reviewers
Maria C. La Via, MD, Associate Professor of Psychiatry, Medical Director of the Eating Disorders Program, University of North Carolina, Chapel Hill, North Carolina; Shareholder: Pfizer (self and spouse).
Christy Maloney, RD, LD/LDN, CPT, Nutritional Therapist, The Renfrew Center: No relevant financial relationships with any commercial interests.
Angela Sims, MPH, RD, LDN, Consultant Dietitian, Genesis Healthcare: No relevant financial relationships with any commercial interests.

John J.D. Juchniewicz, MCIS, CCMEP, American Academy of CME and Deborah Dean, Michelle Yechout, Lisa Cockrell, PhD, and Wendy Gloffke, PhD (editorial assistance provided), peerXchange: No relevant financial relationships with any commercial interests.
This activity will not review off-label or investigational information.
This activity is designed for use by health care professionals for educational purposes only. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or peerXchange. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Accreditation and Credit Designation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Academy of CME, Inc., (Academy) and peerXchange. The American Academy of CME, Inc., is accredited by the ACCME to provide continuing medical education for physicians.
Live Credit Statement
The American Academy of CME, Inc., designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Live Event: April 20, 2015; 7PM (EDT)
Archive Credit Statement
The American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Release date:  April 7, 2015
Expiration date:  April 20, 2016
American Academy of CME, Inc, (AM311) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RD) will receive 1.0 continuing professional education units (CPEUs) for completion of this program. 
Suggested CDR Learning Codes: 4170, 4180, 5320, 5370
Method of Participation & How to Claim Credit
There are no fees to participate in the activity.  After reviewing the CME/CE information including the learning objectives and disclosure statements, learners will complete a brief, 15-minute self-study module. The self-study module provides foundational knowledge which will enable learners to more fully engage the webinar content. Learners will then either participate in the live webinar or view a recording of the event. To receive CME/CE credit for your participation, you will need to complete the activity pre-test, post-test (achieving a passing grade of 70% or greater) and program evaluation at the conclusion of the webinar. Dietitian learners may also submit evaluations of the quality of activities/materials on the CDR website.

For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm
For any questions, please contact: CEServices@academycme.org
© 2015. This CME/CE-certified activity is held as copyrighted © by American Academy of CME, Inc. and peerXchange. Through this notice, the Academy and peerXchange grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Supported Browsers:
Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8    
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6+ for Mac OSX 10.7 and above

For video playback, install the latest version of Flash or Quicktime.